Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032944077> ?p ?o ?g. }
- W2032944077 endingPage "e116" @default.
- W2032944077 startingPage "e113" @default.
- W2032944077 abstract "ObjectiveEarly studies on blood donors point to a seroprevalence of approximately 0.25% for hepatitis C virus (HCV) infection in Iran. However, the true prevalence in the general population is unknown. The objective of this study was to determine the prevalence of HCV infection in the general population of Iran.MethodsWe randomly selected 6583 subjects from three provinces in Iran for inclusion in the study. Subjects were aged between 18 and 65 years. Anti-hepatitis C antibody was tested by a third-generation ELISA test. A recombinant immunoblot assay (RIBA) test was used to confirm the results. Risk factors were recorded and a multivariate analysis was performed.ResultsA total of 5684 plasma samples were tested. After confirmatory tests, we found 50 cases of HCV. The overall weighted prevalence of anti-HCV was 0.5%. The rate was significantly higher in men (1.0%) than in women (0.1%). In multivariate analysis, male sex, history of intravenous drug abuse, and imprisonment were significantly associated with anti-HCV.ConclusionsWe found the prevalence of HCV infection in Iran to be higher than previous estimates. It appears that the rate is rising, and in the future, hepatitis C will replace hepatitis B as the most common cause of chronic viral liver disease in Iran. Early studies on blood donors point to a seroprevalence of approximately 0.25% for hepatitis C virus (HCV) infection in Iran. However, the true prevalence in the general population is unknown. The objective of this study was to determine the prevalence of HCV infection in the general population of Iran. We randomly selected 6583 subjects from three provinces in Iran for inclusion in the study. Subjects were aged between 18 and 65 years. Anti-hepatitis C antibody was tested by a third-generation ELISA test. A recombinant immunoblot assay (RIBA) test was used to confirm the results. Risk factors were recorded and a multivariate analysis was performed. A total of 5684 plasma samples were tested. After confirmatory tests, we found 50 cases of HCV. The overall weighted prevalence of anti-HCV was 0.5%. The rate was significantly higher in men (1.0%) than in women (0.1%). In multivariate analysis, male sex, history of intravenous drug abuse, and imprisonment were significantly associated with anti-HCV. We found the prevalence of HCV infection in Iran to be higher than previous estimates. It appears that the rate is rising, and in the future, hepatitis C will replace hepatitis B as the most common cause of chronic viral liver disease in Iran." @default.
- W2032944077 created "2016-06-24" @default.
- W2032944077 creator A5000444933 @default.
- W2032944077 creator A5014214187 @default.
- W2032944077 creator A5021595674 @default.
- W2032944077 creator A5025337812 @default.
- W2032944077 creator A5031361958 @default.
- W2032944077 creator A5048081316 @default.
- W2032944077 creator A5051197496 @default.
- W2032944077 creator A5055449783 @default.
- W2032944077 creator A5061689322 @default.
- W2032944077 creator A5062397102 @default.
- W2032944077 creator A5070108360 @default.
- W2032944077 creator A5070883823 @default.
- W2032944077 date "2010-09-01" @default.
- W2032944077 modified "2023-10-16" @default.
- W2032944077 title "Seroprevalence of hepatitis C virus: the first population-based study from Iran" @default.
- W2032944077 cites W1967017234 @default.
- W2032944077 cites W1971007519 @default.
- W2032944077 cites W1972573940 @default.
- W2032944077 cites W1984413237 @default.
- W2032944077 cites W2003633275 @default.
- W2032944077 cites W2036925416 @default.
- W2032944077 cites W2044287878 @default.
- W2032944077 cites W2051456286 @default.
- W2032944077 cites W2072639528 @default.
- W2032944077 cites W2102091037 @default.
- W2032944077 cites W2106791445 @default.
- W2032944077 cites W2106975444 @default.
- W2032944077 cites W2116942634 @default.
- W2032944077 cites W2134148226 @default.
- W2032944077 cites W2158470534 @default.
- W2032944077 cites W2166232969 @default.
- W2032944077 cites W1526342018 @default.
- W2032944077 doi "https://doi.org/10.1016/j.ijid.2009.11.032" @default.
- W2032944077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20362479" @default.
- W2032944077 hasPublicationYear "2010" @default.
- W2032944077 type Work @default.
- W2032944077 sameAs 2032944077 @default.
- W2032944077 citedByCount "127" @default.
- W2032944077 countsByYear W20329440772012 @default.
- W2032944077 countsByYear W20329440772013 @default.
- W2032944077 countsByYear W20329440772014 @default.
- W2032944077 countsByYear W20329440772015 @default.
- W2032944077 countsByYear W20329440772016 @default.
- W2032944077 countsByYear W20329440772017 @default.
- W2032944077 countsByYear W20329440772018 @default.
- W2032944077 countsByYear W20329440772019 @default.
- W2032944077 countsByYear W20329440772020 @default.
- W2032944077 countsByYear W20329440772021 @default.
- W2032944077 countsByYear W20329440772022 @default.
- W2032944077 crossrefType "journal-article" @default.
- W2032944077 hasAuthorship W2032944077A5000444933 @default.
- W2032944077 hasAuthorship W2032944077A5014214187 @default.
- W2032944077 hasAuthorship W2032944077A5021595674 @default.
- W2032944077 hasAuthorship W2032944077A5025337812 @default.
- W2032944077 hasAuthorship W2032944077A5031361958 @default.
- W2032944077 hasAuthorship W2032944077A5048081316 @default.
- W2032944077 hasAuthorship W2032944077A5051197496 @default.
- W2032944077 hasAuthorship W2032944077A5055449783 @default.
- W2032944077 hasAuthorship W2032944077A5061689322 @default.
- W2032944077 hasAuthorship W2032944077A5062397102 @default.
- W2032944077 hasAuthorship W2032944077A5070108360 @default.
- W2032944077 hasAuthorship W2032944077A5070883823 @default.
- W2032944077 hasBestOaLocation W20329440771 @default.
- W2032944077 hasConcept C107130276 @default.
- W2032944077 hasConcept C126322002 @default.
- W2032944077 hasConcept C159047783 @default.
- W2032944077 hasConcept C159654299 @default.
- W2032944077 hasConcept C186079640 @default.
- W2032944077 hasConcept C203014093 @default.
- W2032944077 hasConcept C2522874641 @default.
- W2032944077 hasConcept C2776408679 @default.
- W2032944077 hasConcept C2776455275 @default.
- W2032944077 hasConcept C2777072776 @default.
- W2032944077 hasConcept C2778494684 @default.
- W2032944077 hasConcept C2908647359 @default.
- W2032944077 hasConcept C45189115 @default.
- W2032944077 hasConcept C71924100 @default.
- W2032944077 hasConcept C99454951 @default.
- W2032944077 hasConceptScore W2032944077C107130276 @default.
- W2032944077 hasConceptScore W2032944077C126322002 @default.
- W2032944077 hasConceptScore W2032944077C159047783 @default.
- W2032944077 hasConceptScore W2032944077C159654299 @default.
- W2032944077 hasConceptScore W2032944077C186079640 @default.
- W2032944077 hasConceptScore W2032944077C203014093 @default.
- W2032944077 hasConceptScore W2032944077C2522874641 @default.
- W2032944077 hasConceptScore W2032944077C2776408679 @default.
- W2032944077 hasConceptScore W2032944077C2776455275 @default.
- W2032944077 hasConceptScore W2032944077C2777072776 @default.
- W2032944077 hasConceptScore W2032944077C2778494684 @default.
- W2032944077 hasConceptScore W2032944077C2908647359 @default.
- W2032944077 hasConceptScore W2032944077C45189115 @default.
- W2032944077 hasConceptScore W2032944077C71924100 @default.
- W2032944077 hasConceptScore W2032944077C99454951 @default.
- W2032944077 hasLocation W20329440771 @default.
- W2032944077 hasLocation W20329440772 @default.
- W2032944077 hasOpenAccess W2032944077 @default.